Patents Assigned to MediBeacon Development, LLC
  • INTEGRATED PHOTOACTIVE AGENTS AND USES THEREOF
    Publication number: 20130136698
    Abstract: The present invention discloses a number of photoactive compounds designed to bind and inhibit serine proteases. Compounds disclosed herein may be utilized in a number of appropriate medical diagnostic and/or therapeutic procedures such as the monitoring of hemostasis, imaging and/or treatment of vulnerable plaques, and/or tumor imaging and/or treatment.
    Type: Application
    Filed: November 13, 2012
    Publication date: May 30, 2013
    Applicant: MEDIBEACON DEVELOPMENT, LLC
    Inventor: MediBeacon Development, LLC
  • Integrated photoactive agents for real-time monitoring of hemostasis
    Patent number: 8350032
    Abstract: The present invention discloses a number of photoactive compounds designed to bind and inhibit serine proteases. Compounds disclosed herein may be utilized in a number of appropriate medical diagnostic and/or therapeutic procedures such as the monitoring of hemostasis, imaging and/or treatment of vulnerable plaques, and/or tumor imaging and/or treatment.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: January 8, 2013
    Assignee: MediBeacon Development, LLC
    Inventors: William L. Neumann, Richard B. Dorshow